These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 3010939)
1. Activity of recombinant human alpha interferon against influenza virus infection in mice. Sasaki O; Karaki T; Imanishi J Biken J; 1985 Dec; 28(3-4):79-82. PubMed ID: 3010939 [TBL] [Abstract][Full Text] [Related]
2. Interferon and humoral immune response in experimental influenza: infection with A/PR8 virus adapted to the mouse. Lobodzińska M; Albin M Arch Immunol Ther Exp (Warsz); 1980; 28(2):323-8. PubMed ID: 6160829 [TBL] [Abstract][Full Text] [Related]
3. Depression of early protection against influenza virus infection by cyclophosphamide and its restoration by Y-19995 [2,4'-bis(1-methyl-2-dimethyl-aminoethoxyl)-3-benzoylpyridine dimaleate]. Tsuru S; Shinomiya N; Nomoto K Nat Immun Cell Growth Regul; 1991; 10(1):1-11. PubMed ID: 2057018 [TBL] [Abstract][Full Text] [Related]
4. Effect on influenza virus infection on the production of interferon by alveolar and peritoneal cells in vitro. Szulc B; Szalaty H Arch Immunol Ther Exp (Warsz); 1980; 28(1):93-7. PubMed ID: 6158300 [TBL] [Abstract][Full Text] [Related]
5. Protective role of beta interferon in host defense against influenza A virus. Koerner I; Kochs G; Kalinke U; Weiss S; Staeheli P J Virol; 2007 Feb; 81(4):2025-30. PubMed ID: 17151098 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of different mouse interferons in mice infected with encephalomyocarditis (EMC). Lobodzińska M; Albin M Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):49-55. PubMed ID: 6184029 [TBL] [Abstract][Full Text] [Related]
7. Protection from lethal influenza virus challenge by oral type 1 interferon. Beilharz MW; Cummins JM; Bennett AL Biochem Biophys Res Commun; 2007 Apr; 355(3):740-4. PubMed ID: 17316562 [TBL] [Abstract][Full Text] [Related]
8. Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. Tsurita M; Kurokawa M; Imakita M; Fukuda Y; Watanabe Y; Shiraki K J Pharmacol Exp Ther; 2001 Jul; 298(1):362-8. PubMed ID: 11408563 [TBL] [Abstract][Full Text] [Related]
9. Recombinant mouse beta-defensin 2 inhibits infection by influenza A virus by blocking its entry. Gong T; Jiang Y; Wang Y; Yang D; Li W; Zhang Q; Feng W; Wang B; Jiang Z; Li M Arch Virol; 2010 Apr; 155(4):491-8. PubMed ID: 20195655 [TBL] [Abstract][Full Text] [Related]
10. Antiviral effects of rhIFN-alpha 1 against seven influenza viruses. Li F; Wang QJ; Zhu BL; Wang M Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):709-14. PubMed ID: 10678103 [TBL] [Abstract][Full Text] [Related]
11. Mx1 but not MxA confers resistance against tick-borne Dhori virus in mice. Thimme R; Frese M; Kochs G; Haller O Virology; 1995 Aug; 211(1):296-301. PubMed ID: 7645224 [TBL] [Abstract][Full Text] [Related]
12. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. James CM; Abdad MY; Mansfield JP; Jacobsen HK; Vind AR; Stumbles PA; Bartlett EJ Vaccine; 2007 Feb; 25(10):1856-67. PubMed ID: 17240000 [TBL] [Abstract][Full Text] [Related]
14. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells. Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo influenza virus-inhibitory effects of viramidine. Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250 [TBL] [Abstract][Full Text] [Related]